{"name":"PADAGIS US","slug":"padagis-us","ticker":"","exchange":"","domain":"padagisus.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":2800000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[{"name":"Verdeso","genericName":"DESONIDE","slug":"desonide","revenue":2800000000,"yoyGrowth":0,"percentOfTotal":100}],"timeline":[{"date":"1972-01-01","label":"Verdeso first approved","drug":"Verdeso","drugSlug":"desonide","type":"approval","sentiment":"positive"},{"date":"1981-01-01","label":"Midamor first approved","drug":"Midamor","drugSlug":"amiloride","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-08-13","label":"Verdeso patent expiry (Formulation)","drug":"Verdeso","drugSlug":"desonide","type":"patent_expiry","sentiment":"negative"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":2800000000,"percentOfTotal":100,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Verdeso","genericName":"DESONIDE","slug":"desonide","indication":"Allergic Rhinitis Prevention","status":"marketed","revenue":2800000000}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Midamor","genericName":"AMILORIDE","slug":"amiloride","indication":"Edema","status":"marketed"}]}],"pipeline":[{"name":"Verdeso","genericName":"DESONIDE","slug":"desonide","phase":"marketed","mechanism":"Glucocorticoid receptor","indications":["Allergic Rhinitis Prevention","Allergic rhinitis","Asthma","Asthma management","Atopic dermatitis"],"catalyst":""},{"name":"Midamor","genericName":"AMILORIDE","slug":"amiloride","phase":"marketed","mechanism":"Amiloride-sensitive sodium channel, ENaC","indications":["Edema","Hypertensive disorder","Hypokalemia Prevention"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[{"drugName":"Verdeso","drugSlug":"desonide","patentNumber":"8460641","type":"Formulation","expiryDate":"2027-08-13","territory":"US","annualRevenue":2800000000,"genericFilings":[]}],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}